Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.
Magni R, Espina BH, Shah K, Lepene B, Mayuga C, Douglas TA, Espina V, Rucker S, Dunlap R, Petricoin EF, Kilavos MF, Poretz DM, Irwin GR, Shor SM, Liotta LA, Luchini A. Magni R, et al. Among authors: poretz dm. J Transl Med. 2015 Nov 4;13:346. doi: 10.1186/s12967-015-0701-z. J Transl Med. 2015. PMID: 26537892 Free PMC article.
Ceftriaxone therapy of serious bacterial infections.
Eron LJ, Park CH, Goldenberg RI, Poretz DM. Eron LJ, et al. Among authors: poretz dm. J Antimicrob Chemother. 1983 Jul;12(1):65-78. doi: 10.1093/jac/12.1.65. J Antimicrob Chemother. 1983. PMID: 6311783
Antibiotic therapy of osteomyelitis in outpatients.
Ingram C, Eron LJ, Goldenberg RI, Morrison AJ Jr, Poretz DM, Alder ME, Harvey LK, Rising JB, Sparks SB. Ingram C, et al. Among authors: poretz dm. Med Clin North Am. 1988 May;72(3):723-38. doi: 10.1016/s0025-7125(16)30768-4. Med Clin North Am. 1988. PMID: 3352376
Outpatient parenteral antibiotic therapy.
Poretz DM. Poretz DM. Int J Antimicrob Agents. 1995 Jan;5(1):9-12. doi: 10.1016/0924-8579(94)00041-r. Int J Antimicrob Agents. 1995. PMID: 18611638
High tech comes home.
Poretz DM. Poretz DM. Am J Med. 1991 Nov;91(5):453-4. doi: 10.1016/0002-9343(91)90179-2. Am J Med. 1991. PMID: 1951406 No abstract available.
Imipenem versus moxalactam in the treatment of serious infections.
Eron LJ, Hixon DL, Park CH, Goldenberg RI, Poretz DM. Eron LJ, et al. Among authors: poretz dm. Antimicrob Agents Chemother. 1983 Dec;24(6):841-6. doi: 10.1128/AAC.24.6.841. Antimicrob Agents Chemother. 1983. PMID: 6581755 Free PMC article. Clinical Trial.
Piperacillin therapy for Pseudomonas infections.
Eron LJ, Goldenberg RI, Poretz DM, Park CH. Eron LJ, et al. Among authors: poretz dm. South Med J. 1983 Jul;76(7):859-62. doi: 10.1097/00007611-198307000-00010. South Med J. 1983. PMID: 6223378
Intravenous antibiotic therapy in ambulatory pediatric patients.
Goldenberg RI, Poretz DM, Eron LJ, Rising JB, Sparks SB. Goldenberg RI, et al. Among authors: poretz dm. Pediatr Infect Dis. 1984 Nov-Dec;3(6):514-7. doi: 10.1097/00006454-198411000-00006. Pediatr Infect Dis. 1984. PMID: 6514592
Home management of antibiotic therapy.
Poretz DM. Poretz DM. Curr Clin Top Infect Dis. 1989;10:27-42. Curr Clin Top Infect Dis. 1989. PMID: 2679697 Review. No abstract available.
Home IV programs.
Poretz DM. Poretz DM. Cost Containment. 1983 Feb 22;5(4):3-4. Cost Containment. 1983. PMID: 10258194 No abstract available.
Managed care and the infectious diseases specialist.
Tice AD, Slama TG, Berman S, Braun P, Burke JP, Cherney A, Gross PA, Harris P, Reid-Hatton M, Hoffman R, Joseph P, Lawton S, Massanari RM, Miller ZI, Osheroff WJ, Poretz D, Shalowitz M, Simmons B, Turner JP, Wade B, Nolet BR. Tice AD, et al. Clin Infect Dis. 1996 Aug;23(2):341-68. doi: 10.1093/clinids/23.2.341. Clin Infect Dis. 1996. PMID: 8842275 Review.
Ceftazidime therapy of serious bacterial infections.
Eron LJ, Goldenberg RI, Park CH, Poretz DM. Eron LJ, et al. Among authors: poretz dm. Antimicrob Agents Chemother. 1983 Feb;23(2):236-41. doi: 10.1128/AAC.23.2.236. Antimicrob Agents Chemother. 1983. PMID: 6340601 Free PMC article. Clinical Trial.
Ceftazidime in patients with Pseudomonas infections.
Eron LJ, Park CH, Hixon DL, Goldenberg RI, Poretz DM. Eron LJ, et al. Among authors: poretz dm. J Antimicrob Chemother. 1983 Jul;12 Suppl A:161-9. doi: 10.1093/jac/12.suppl_a.161. J Antimicrob Chemother. 1983. PMID: 6225762 Clinical Trial.
Erysipelothrix endocarditis with cutaneous lesion.
Park CH, Poretz DM, Goldenberg R. Park CH, et al. Among authors: poretz dm. South Med J. 1976 Aug;69(8):1101-3. South Med J. 1976. PMID: 986691 No abstract available.
The private practice of infectious diseases.
Poretz DM. Poretz DM. J Infect Dis. 1983 Mar;147(3):417-21. doi: 10.1093/infdis/147.3.417. J Infect Dis. 1983. PMID: 6833790 No abstract available.
Use of amoxicillin in the treatment of urinary tract infections.
Miller GB Jr, Duma RJ, Middleton FG, Poretz DM. Miller GB Jr, et al. Among authors: poretz dm. J Infect Dis. 1974 Jun;129(0):suppl:S237-40. doi: 10.1093/infdis/129.supplement_2.s237. J Infect Dis. 1974. PMID: 4601194 No abstract available.
Ritonavir and saquinavir combination therapy for the treatment of HIV infection.
Cameron DW, Japour AJ, Xu Y, Hsu A, Mellors J, Farthing C, Cohen C, Poretz D, Markowitz M, Follansbee S, Angel JB, McMahon D, Ho D, Devanarayan V, Rode R, Salgo M, Kempf DJ, Granneman R, Leonard JM, Sun E. Cameron DW, et al. AIDS. 1999 Feb 4;13(2):213-24. doi: 10.1097/00002030-199902040-00009. AIDS. 1999. PMID: 10202827 Clinical Trial.
It's Not Just the Hospital Anymore.
Poretz DM. Poretz DM. Curr Infect Dis Rep. 2003 Aug;5(4):277-278. doi: 10.1007/s11908-003-0001-2. Curr Infect Dis Rep. 2003. PMID: 12866977 No abstract available.
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.
Ledgerwood JE, Hu Z, Costner P, Yamshchikov G, Enama ME, Plummer S, Hendel CS, Holman L, Larkin B, Gordon I, Bailer RT, Poretz DM, Sarwar U, Kabadi A, Koup R, Mascola JR, Graham BS; VRC 307 and VRC 309 Study Teams. Ledgerwood JE, et al. Among authors: poretz dm. Contemp Clin Trials. 2015 Sep;44:112-118. doi: 10.1016/j.cct.2015.08.006. Epub 2015 Aug 12. Contemp Clin Trials. 2015. PMID: 26275339 Free PMC article.
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.
Birx DL, Loomis-Price LD, Aronson N, Brundage J, Davis C, Deyton L, Garner R, Gordin F, Henry D, Holloway W, Kerkering T, Luskin-Hawk R, McNeil J, Michael N, Foster Pierce P, Poretz D, Ratto-Kim S, Renzullo P, Ruiz N, Sitz K, Smith G, Tacket C, Thompson M, Tramont E, Yangco B, Yarrish R, Redfield RR. Birx DL, et al. J Infect Dis. 2000 Mar;181(3):881-9. doi: 10.1086/315308. J Infect Dis. 2000. PMID: 10720508 Clinical Trial.
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, Adams E, DeJesus E, Novak RM, Frank I, Bentley C, Ramirez S, Fu R, Koup RA, Mascola JR, Nabel GJ, Montefiori DC, Kublin J, McElrath MJ, Corey L, Gilbert PB; HVTN 505 Study Team. Hammer SM, et al. N Engl J Med. 2013 Nov 28;369(22):2083-92. doi: 10.1056/NEJMoa1310566. Epub 2013 Oct 7. N Engl J Med. 2013. PMID: 24099601 Free PMC article. Clinical Trial.
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials.
Eron JJ, Young B, Cooper DA, Youle M, Dejesus E, Andrade-Villanueva J, Workman C, Zajdenverg R, Fätkenheuer G, Berger DS, Kumar PN, Rodgers AJ, Shaughnessy MA, Walker ML, Barnard RJ, Miller MD, Dinubile MJ, Nguyen BY, Leavitt R, Xu X, Sklar P; SWITCHMRK 1 and 2 investigators. Eron JJ, et al. Lancet. 2010 Jan 30;375(9712):396-407. doi: 10.1016/S0140-6736(09)62041-9. Epub 2010 Jan 12. Lancet. 2010. PMID: 20074791 Clinical Trial.
Chronic meningococcemia.
Dineen JF, Poretz DM. Dineen JF, et al. Among authors: poretz dm. Va Med Mon (1918). 1975 Nov;102(11):957-8. Va Med Mon (1918). 1975. PMID: 1199416 No abstract available.